Have you been affected by Transvaginal Mesh?
Transvaginal mesh is a loosely woven surgical mesh made of polypropylene used as a temporary or permanent support for conditions like inguinal hernia, pelvic organ prolapse (POP), and stress urinary incontinence (SUI) which are often a result of a menopause, hysterectomy, or childbirth. Simply put, transvaginal mesh is a device that is used to provide more support to repairing weakened or damaged tissue.
Recent medical studies have confirmed that Transvaginal Mesh (TVM) and Pelvic and Bladder Supports and Slings have resulted in serious complications which include but are not limited to: chronic pain, infections, painful intercourse, migration, “erosion “ (a dangerous, painful condition where the skin splits and the mesh protrudes) and the need for corrective surgeries.
The US Food and Drug Administration (FDA) approved the first transvaginal mesh device for use in 1996 which was manufactured by Boston Scientific Corporation. The first transvaginal mesh, specifically manufactured for repairing pelvic organ prolapse (POP) by Johnson & Johnson’s Ethicon Unit, was released in 2002.
In July 2011 the Food and Drug Administration (FDA) issued a safety alert and warned that serious complications associated with the transvaginal mesh method of Pelvic Organ Prolapse (POP) correction are not rare. The FDA also announced that, in addition to posing greater risks, mesh patches might be no more effective than traditional repair methods. In January 2012 the FDA ordered makers of transvaginal mesh to study the risks associated with the devices.
It has been estimated that, by 2010, over 100,000 women had transvaginal meshes implanted, usually to treat pelvic organ prolapse (POP). As a matter of fact, in 2010, three out of four procedures to treat POP with mesh were carried out transvaginally. Also, the same year, 260,000 women had transvaginal mesh surgery to treat stress urinary incontinence (SUI).
Transvaginal Mesh (TVM) lawsuits have been filed against TVM manufacturers and the number continues to grow as more and more women stand up for themselves against the manufacturers of transvaginal mesh that caused them so much suffering.
According to Drugwatch, five companies dominate the TVM market; Johnson & Johnson, Bard Medical, American Medical Solutions, Boston Scientific and Coloplast.